Article Detail - JE Part B
MolDX: Biomarker Testing for Risk Stratification in DCIS - Published for Review and Comments
Date Posted: July 17, 2025
This proposed Local Coverage Determination (LCD) has been published for review and comments for contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).
Medicare Coverage Database (MCD) Number: DL40144
LCD Title: MolDX: Biomarker Testing for Risk Stratification in DCIS
Comment period: July 17, 2025 - August 31, 2025
Visit the CMS MCD to access Proposed LCDs not released to final LCDs.
Providers may address details for comment submission. When sending comments, reference the specific policy to which they are related. See the Proposed MolDX LCDs webpage for email and mail specifics.